Software As A Medical Device Market Size, Trends, Segments And Forecast To 2033 |Apple Inc., McKesson Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH

Spread the love

The (SaMD) Software As A Medical Device Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The (SaMD) Software As A Medical Device Market:

https://www.thebusinessresearchcompany.com/report/samd-software-as-a-medical-device-global-market-report

According to The Business Research Company’s (SaMD) Software As A Medical Device Global Market Report 2024, The (samd) software as a medical device market size has grown exponentially in recent years. It will grow from $24.29 billion in 2023 to $30.4 billion in 2024 at a compound annual growth rate (CAGR) of 25.2%. The growth in the historic period can be attributed to globalization, rising complexity of challenges, market dynamics, shared research and development costs, sustainability goals.

The (samd) software as a medical device market size is expected to see exponential growth in the next few years. It will grow to $74.86 billion in 2028 at a compound annual growth rate (CAGR) of 25.3%. The growth in the forecast period can be attributed to regulatory changes, cybersecurity concerns, ai and data analytics, global health crises response, blockchain for trust and transparency. Major trends in the forecast period include ecosystem partnership, rapid technological obsolescence, digital transformation, access to new technologies, innovation imperative, technological advancements.

The rising adoption of IoT in the healthcare sector is expected to propel the growth of the software as a medical device (SaMD) market going forward. IoT in healthcare is defined as medical tools and software that can communicate with online computer networks to access healthcare information technology systems. Remote patient monitoring is one of the critical applications of the IoT (Internet of Things) in the healthcare sector. It involves using connected devices and sensors to monitor patients’ health status and collect data remotely. IoT-based telemedicine is used together in the healthcare sector, as it is an innovative technology with the potential to revolutionize the way healthcare is delivered, which results in proactive interventions, individualized care, improved patient outcomes, and enhanced privacy. For instance, in May 2023, according to Medicon Publications, a US-based international publisher with open access journals, in 2021, 80% of Americans were in favor of using remote patient monitoring, and 30 million patients in the US are anticipated to use remote patient monitoring technologies and services by 2024. Furthermore, in October 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, In the year 2021, telemedicine was utilized by 37.0% of individuals, which increased with age and was more prevalent among women (42.0%) than among men (31.7%). Therefore, the rising adoption of IoT in healthcare is driving the growth of the software as a medical device (SaMD) market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12446&type=smp

The (samd) software as a medical device market covered in this report is segmented –

1) By Device Type: Wearable Device, PCs And Laptop, Smartphone And Tablets

2) By Deployment Method: Cloud-Based, On-Premise

3) By Application: Diagnostic, Clinical Management

AI-powered software is a key trend gaining popularity in the software as a medical device (SaMD) market. Major companies operating in the software as a medical device (SaMD) market are developing innovative AI-powered software to sustain their position in the market. For instance, in May 2023, Genomic Vision., a France-based biotechnology company, launched AI-powered software called FiberSmart. This innovative software is designed to automate the detection and quantification of fluorescent signals on combed DNA molecules. It can be used to analyze DNA replication kinetics, which is the process of DNA copying. This technology allows DNA molecules to be aligned and separated, making detecting and quantifying fluorescent signals easier. Additionally, it includes AI-powered detection and quantification, a user-friendly interface, and is flexible and scalable. And it is beneficial as it is compatible with Genomic Vision’s suite of scanners and has been successfully tested and validated.

The (samd) software as a medical device market report table of contents includes:

1. Executive Summary

2. Software As A Medical Device (SaMD) Market Characteristics

3. Software As A Medical Device (SaMD) Market Trends And Strategies

4. Software As A Medical Device (SaMD) Market – Macro Economic Scenario

5. Global Software As A Medical Device (SaMD) Market Size and Growth

32. Global Software As A Medical Device (SaMD) Market Competitive Benchmarking

33. Global Software As A Medical Device (SaMD) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Software As A Medical Device (SaMD) Market

35. Software As A Medical Device (SaMD) Market Future Outlook and Potential Analysis

36. Appendix

Top Major Players :